Standout Papers

<i>p53</i> Status and the Efficacy of Cancer Therapy in Vivo 1994 2026 2004 2015 1.2k
  1. p53 Status and the Efficacy of Cancer Therapy in Vivo (1994)
    Scott W. Lowe, Stephan Bodis et al. Science
  2. Apoptosis in cancer therapy: Crossing the threshold (1994)
    David E. Fisher Cell
  3. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma (2005)
    Levi A. Garraway, Hans R. Widlund et al. Nature
  4. Melanocyte biology and skin pigmentation (2007)
    Jennifer Y. Lin, David E. Fisher Nature
  5. MITF: master regulator of melanocyte development and melanoma oncogene (2006)
    Carmit Levy, Mehdi Khaled et al. Trends in Molecular Medicine
  6. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target (2017)
    Robert T. Manguso, Hans W. Pope et al. Nature
  7. Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF (2013)
    Rizwan Haq, Jonathan E. Shoag et al. Cancer Cell
  8. Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function (2010)
    Andrea Boni, Alexandria P. Cogdill et al. Cancer Research
  9. Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability (2002)
    Gaël McGill, Martin A. Horstmann et al. Cell
  10. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. (1994)
    Timothy J. Hemesath, Eirı́kur Steingrı́msson et al. Genes & Development
  11. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes (1998)
    Timothy J. Hemesath, Edwin R. Price et al. Nature
  12. Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche (2004)
    Emi K. Nishimura, Scott R. Granter et al. Science
  13. Melanoma (2015)
    Dirk Schadendorf, David E. Fisher et al. Nature Reviews Disease Primers
  14. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy (2019)
    Melvyn T. Chow, Aleksandra J. Ozga et al. Immunity
  15. A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors (2014)
    David J. Konieczkowski, Cory M. Johannessen et al. Cancer Discovery

Immediate Impact

2 by Nobel laureates 49 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

SOX17 enables immune evasion of early colorectal adenomas and cancers
2024 StandoutNature
CRISPR technology: A decade of genome editing is only the beginning
2023 StandoutScienceNobel

Works of David E. Fisher being referenced

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
2017 StandoutNature

Author Peers

Author Last Decade Papers Cites
David E. Fisher 18258 9444 9742 390 33.0k
Gerd Schmitz 14117 2217 5332 650 31.4k
Albert J. Fornace 25494 3004 12815 409 35.4k
Pier Giuseppe Pelicci 31361 3342 9522 526 45.1k
Harvey F. Lodish 46181 11479 9029 572 76.6k
Richard J. Simpson 27061 2206 5186 552 41.6k
Susan E. Bates 19797 1323 22612 440 37.9k
Jerry W. Shay 34712 2104 8781 512 56.7k
Zbigniew Darżynkiewicz 22321 2524 6937 647 36.5k
Leonard I. Zon 29107 17665 4349 483 48.0k
Jan H.J. Hoeijmakers 37648 2786 7748 394 47.2k

All Works

Loading papers...

Rankless by CCL
2026